The primary objectives of this study are to assess the sensitivity and specificity of SGM-101 in detecting non-small cell lung carcinomas during surgery when excited by an near-infrared light source utilizing intraoperative imaging.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Sensitivity measure of SGM-101 uptake and expression in identifying non-small cell lung cancer
Timeframe: Up to 10 days post surgery (completion of pathology report)
Specificity measure of SGM-101 uptake and expression in identifying non-small cell lung cancer
Timeframe: Up to 10 days post surgery (completion of pathology report)
Number of Adverse Events (AEs) and Treatment-emergent Adverse Events (TEAEs)
Timeframe: Up to 4 weeks post surgery (completion of post-operative follow-up visit)